

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.36184286 |
| 2 | axonemal dynein complex assembly (GO:0070286) | 4.32947759 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.07948306 |
| 4 | drug catabolic process (GO:0042737) | 4.03902816 |
| 5 | exogenous drug catabolic process (GO:0042738) | 3.92083842 |
| 6 | cilium movement (GO:0003341) | 3.87266053 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 3.61247202 |
| 8 | ethanol metabolic process (GO:0006067) | 3.61059760 |
| 9 | ethanol oxidation (GO:0006069) | 3.55368987 |
| 10 | epithelial cilium movement (GO:0003351) | 3.47227986 |
| 11 | motile cilium assembly (GO:0044458) | 3.11164987 |
| 12 | primary alcohol catabolic process (GO:0034310) | 2.95246470 |
| 13 | drug metabolic process (GO:0017144) | 2.88568366 |
| 14 | macroautophagy (GO:0016236) | 2.86191470 |
| 15 | axoneme assembly (GO:0035082) | 2.85404422 |
| 16 | flavonoid metabolic process (GO:0009812) | 2.84774016 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 2.82619776 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 2.82619776 |
| 19 | tryptophan catabolic process (GO:0006569) | 2.82619776 |
| 20 | toxin transport (GO:1901998) | 2.77253996 |
| 21 | negative regulation of humoral immune response (GO:0002921) | 2.77122531 |
| 22 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74865270 |
| 23 | cellular glucuronidation (GO:0052695) | 2.74572759 |
| 24 | drug transmembrane transport (GO:0006855) | 2.70262836 |
| 25 | drug transport (GO:0015893) | 2.68459436 |
| 26 | glucuronate metabolic process (GO:0019585) | 2.68053780 |
| 27 | uronic acid metabolic process (GO:0006063) | 2.68053780 |
| 28 | quaternary ammonium group transport (GO:0015697) | 2.67774675 |
| 29 | negative regulation of complement activation (GO:0045916) | 2.58892650 |
| 30 | regulation of protein activation cascade (GO:2000257) | 2.58539974 |
| 31 | regulation of complement activation (GO:0030449) | 2.58318975 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 2.57225043 |
| 33 | negative regulation of protein activation cascade (GO:2000258) | 2.53218158 |
| 34 | bile acid and bile salt transport (GO:0015721) | 2.52931508 |
| 35 | bile acid metabolic process (GO:0008206) | 2.50033288 |
| 36 | bile acid biosynthetic process (GO:0006699) | 2.48353741 |
| 37 | complement activation, alternative pathway (GO:0006957) | 2.45233029 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 2.43499557 |
| 39 | organic cation transport (GO:0015695) | 2.42298525 |
| 40 | alkaloid metabolic process (GO:0009820) | 2.39352173 |
| 41 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.37391603 |
| 42 | carnitine transport (GO:0015879) | 2.37259854 |
| 43 | amino-acid betaine transport (GO:0015838) | 2.37259854 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 2.35388406 |
| 45 | oxidative demethylation (GO:0070989) | 2.35209421 |
| 46 | primary alcohol metabolic process (GO:0034308) | 2.33140198 |
| 47 | phenol-containing compound catabolic process (GO:0019336) | 2.32066256 |
| 48 | positive regulation of icosanoid secretion (GO:0032305) | 2.30012294 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28655969 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 2.28655969 |
| 51 | phenylpropanoid metabolic process (GO:0009698) | 2.25408041 |
| 52 | fucose catabolic process (GO:0019317) | 2.24841576 |
| 53 | L-fucose metabolic process (GO:0042354) | 2.24841576 |
| 54 | L-fucose catabolic process (GO:0042355) | 2.24841576 |
| 55 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.24315365 |
| 56 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.24315365 |
| 57 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.22949946 |
| 58 | excretion (GO:0007588) | 2.22333681 |
| 59 | arginine metabolic process (GO:0006525) | 2.18548336 |
| 60 | positive regulation of fatty acid transport (GO:2000193) | 2.18318757 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 2.18115948 |
| 62 | cellular response to exogenous dsRNA (GO:0071360) | 2.16049163 |
| 63 | positive regulation of fatty acid oxidation (GO:0046321) | 2.15846557 |
| 64 | xenobiotic metabolic process (GO:0006805) | 2.15340316 |
| 65 | carnitine transmembrane transport (GO:1902603) | 2.15231886 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 2.15179262 |
| 67 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.14314466 |
| 68 | vitamin transmembrane transport (GO:0035461) | 2.13212683 |
| 69 | angiotensin maturation (GO:0002003) | 2.12657190 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 2.11637912 |
| 71 | glyoxylate metabolic process (GO:0046487) | 2.11431516 |
| 72 | thyroid hormone metabolic process (GO:0042403) | 2.10784313 |
| 73 | one-carbon compound transport (GO:0019755) | 2.10408886 |
| 74 | tryptophan metabolic process (GO:0006568) | 2.09793440 |
| 75 | digestion (GO:0007586) | 2.09193400 |
| 76 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.08787740 |
| 77 | sulfate transmembrane transport (GO:1902358) | 2.08402859 |
| 78 | arginine catabolic process (GO:0006527) | 2.08026977 |
| 79 | regulation of cilium movement (GO:0003352) | 2.05944275 |
| 80 | L-phenylalanine metabolic process (GO:0006558) | 2.05700889 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.05700889 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 2.05618151 |
| 83 | amine catabolic process (GO:0009310) | 2.05618151 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.04392734 |
| 85 | thyroid hormone generation (GO:0006590) | 2.03628607 |
| 86 | positive regulation of digestive system process (GO:0060456) | 2.02550462 |
| 87 | high-density lipoprotein particle remodeling (GO:0034375) | 2.01142110 |
| 88 | neurotransmitter biosynthetic process (GO:0042136) | 2.00767240 |
| 89 | reactive oxygen species biosynthetic process (GO:1903409) | 1.99664160 |
| 90 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 1.98752502 |
| 91 | phosphate ion homeostasis (GO:0055062) | 1.97284767 |
| 92 | trivalent inorganic anion homeostasis (GO:0072506) | 1.97284767 |
| 93 | parturition (GO:0007567) | 1.96363083 |
| 94 | multicellular organismal water homeostasis (GO:0050891) | 1.94984058 |
| 95 | water homeostasis (GO:0030104) | 1.94775915 |
| 96 | neurotransmitter metabolic process (GO:0042133) | 1.94408939 |
| 97 | lung secretory cell differentiation (GO:0061140) | 1.93873901 |
| 98 | glomerular filtration (GO:0003094) | 1.93745674 |
| 99 | amyloid precursor protein catabolic process (GO:0042987) | 1.93695298 |
| 100 | diterpenoid biosynthetic process (GO:0016102) | 1.93690079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51080884 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.39562026 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.24169305 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.08819383 |
| 5 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.98683699 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.84043107 |
| 7 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.78314205 |
| 8 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.69512763 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68757997 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64948319 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.63883704 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63518704 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62431158 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60046424 |
| 15 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57848750 |
| 16 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48909773 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45788792 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.45334133 |
| 19 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.42698128 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.42285619 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38808321 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37459124 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37310184 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35287246 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29427455 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28112301 |
| 27 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.27659110 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25679052 |
| 29 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25653313 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25634131 |
| 31 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23694692 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21506260 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15786188 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12725043 |
| 35 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12521975 |
| 36 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.11064710 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10468524 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10428551 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10009874 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09931389 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08424208 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07958555 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07175228 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02092076 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01997146 |
| 46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01279758 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01089426 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01001726 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00445244 |
| 50 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00017523 |
| 51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98246136 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98160121 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96168173 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94588287 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91821611 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91814218 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91731412 |
| 58 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91629354 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91019729 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.90150435 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.89097468 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88954972 |
| 63 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88374592 |
| 64 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88097960 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87947097 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87947097 |
| 67 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.87696821 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87499496 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86783276 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86277683 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85065990 |
| 72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84539956 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84042777 |
| 74 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83946006 |
| 75 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83766041 |
| 76 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83068481 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83000956 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82887108 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82114591 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.81343128 |
| 81 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81171612 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80711980 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80486998 |
| 84 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80111167 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79967248 |
| 86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79033324 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78813653 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78476628 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78282402 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77875894 |
| 91 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.77859656 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77138544 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76924942 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 0.76281212 |
| 95 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76112052 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75826125 |
| 97 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.74782049 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.74277273 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73771122 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73661797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.77425743 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 3.56452579 |
| 3 | MP0003195_calcinosis | 3.48986998 |
| 4 | MP0005365_abnormal_bile_salt | 3.43658741 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.15354214 |
| 6 | MP0005360_urolithiasis | 2.81213972 |
| 7 | MP0004043_abnormal_pH_regulation | 2.69592581 |
| 8 | MP0002876_abnormal_thyroid_physiology | 2.48394941 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.45764775 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.18127578 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.12851187 |
| 12 | MP0010329_abnormal_lipoprotein_level | 1.91477592 |
| 13 | MP0000383_abnormal_hair_follicle | 1.90888451 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 1.87959376 |
| 15 | MP0008004_abnormal_stomach_pH | 1.86478584 |
| 16 | MP0003252_abnormal_bile_duct | 1.84641459 |
| 17 | MP0005083_abnormal_biliary_tract | 1.78945607 |
| 18 | MP0003724_increased_susceptibility_to | 1.77638357 |
| 19 | MP0001756_abnormal_urination | 1.74957643 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.72869979 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.69939959 |
| 22 | MP0002653_abnormal_ependyma_morphology | 1.69182465 |
| 23 | MP0009840_abnormal_foam_cell | 1.66433271 |
| 24 | MP0001765_abnormal_ion_homeostasis | 1.63517956 |
| 25 | MP0001664_abnormal_digestion | 1.55856911 |
| 26 | MP0010386_abnormal_urinary_bladder | 1.52686399 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.52565801 |
| 28 | MP0010678_abnormal_skin_adnexa | 1.51358098 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.45387037 |
| 30 | MP0003011_delayed_dark_adaptation | 1.44581729 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.44402038 |
| 32 | MP0005332_abnormal_amino_acid | 1.37388441 |
| 33 | MP0002132_abnormal_respiratory_system | 1.31828613 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.29938464 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.29145188 |
| 36 | MP0001873_stomach_inflammation | 1.28106173 |
| 37 | MP0002136_abnormal_kidney_physiology | 1.26659898 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.26506016 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.23823411 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.21106214 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.18797047 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.18598521 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.18547670 |
| 44 | MP0002168_other_aberrant_phenotype | 1.18450349 |
| 45 | MP0001663_abnormal_digestive_system | 1.16230305 |
| 46 | MP0003868_abnormal_feces_composition | 1.13795828 |
| 47 | MP0008872_abnormal_physiological_respon | 1.12885868 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.12551568 |
| 49 | MP0004885_abnormal_endolymph | 1.11812562 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.10373623 |
| 51 | MP0004133_heterotaxia | 1.08745588 |
| 52 | MP0000230_abnormal_systemic_arterial | 1.07012911 |
| 53 | MP0004883_abnormal_blood_vessel | 1.04386038 |
| 54 | MP0003879_abnormal_hair_cell | 1.04115949 |
| 55 | MP0003866_abnormal_defecation | 1.04052966 |
| 56 | MP0003878_abnormal_ear_physiology | 1.03152164 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.03152164 |
| 58 | MP0005310_abnormal_salivary_gland | 1.02174873 |
| 59 | MP0000470_abnormal_stomach_morphology | 1.01474524 |
| 60 | MP0006082_CNS_inflammation | 1.00804971 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.00703703 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 0.98040499 |
| 63 | MP0002254_reproductive_system_inflammat | 0.97190544 |
| 64 | MP0005381_digestive/alimentary_phenotyp | 0.95116705 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.93904525 |
| 66 | MP0005164_abnormal_response_to | 0.90618951 |
| 67 | MP0001764_abnormal_homeostasis | 0.90572604 |
| 68 | MP0003045_fibrosis | 0.90517121 |
| 69 | MP0009764_decreased_sensitivity_to | 0.90388764 |
| 70 | MP0005409_darkened_coat_color | 0.88600523 |
| 71 | MP0000427_abnormal_hair_cycle | 0.85542624 |
| 72 | MP0003303_peritoneal_inflammation | 0.85051447 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.83907754 |
| 74 | MP0001958_emphysema | 0.82762029 |
| 75 | MP0005448_abnormal_energy_balance | 0.82357529 |
| 76 | MP0005025_abnormal_response_to | 0.82331298 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.82007283 |
| 78 | MP0009785_altered_susceptibility_to | 0.80063588 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.79582043 |
| 80 | MP0005595_abnormal_vascular_smooth | 0.76967449 |
| 81 | MP0008469_abnormal_protein_level | 0.76964365 |
| 82 | MP0003300_gastrointestinal_ulcer | 0.76644262 |
| 83 | MP0005670_abnormal_white_adipose | 0.75823524 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.74843934 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.74674472 |
| 86 | MP0005408_hypopigmentation | 0.73132930 |
| 87 | MP0003953_abnormal_hormone_level | 0.73100859 |
| 88 | MP0000681_abnormal_thyroid_gland | 0.72357617 |
| 89 | MP0001835_abnormal_antigen_presentation | 0.72112726 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.71810691 |
| 91 | MP0000249_abnormal_blood_vessel | 0.71658109 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.70796490 |
| 93 | MP0000566_synostosis | 0.69180682 |
| 94 | MP0002419_abnormal_innate_immunity | 0.67309673 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.67295739 |
| 96 | MP0000516_abnormal_urinary_system | 0.67295739 |
| 97 | MP0000604_amyloidosis | 0.66990354 |
| 98 | MP0001790_abnormal_immune_system | 0.66836198 |
| 99 | MP0005387_immune_system_phenotype | 0.66836198 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.66345320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent/shortened dynein arms (HP:0200106) | 5.32799386 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.32799386 |
| 3 | Abnormal ciliary motility (HP:0012262) | 4.89250960 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.88646784 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.88646784 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.47103754 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.45559875 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 4.19252591 |
| 9 | Rhinitis (HP:0012384) | 3.73348588 |
| 10 | Decreased circulating renin level (HP:0003351) | 3.38720740 |
| 11 | Complement deficiency (HP:0004431) | 3.05504777 |
| 12 | Chronic bronchitis (HP:0004469) | 3.01256179 |
| 13 | Abnormality of renin-angiotensin system (HP:0000847) | 2.98840286 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 2.96782562 |
| 15 | Bronchiectasis (HP:0002110) | 2.95917913 |
| 16 | Tubular atrophy (HP:0000092) | 2.95167796 |
| 17 | Hyperaldosteronism (HP:0000859) | 2.94270686 |
| 18 | Metabolic alkalosis (HP:0200114) | 2.93131635 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91175260 |
| 20 | True hermaphroditism (HP:0010459) | 2.77502019 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73377146 |
| 22 | Abnormality of chloride homeostasis (HP:0011422) | 2.73014741 |
| 23 | Renal salt wasting (HP:0000127) | 2.72829529 |
| 24 | Pancreatic cysts (HP:0001737) | 2.69154654 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 2.69018160 |
| 26 | Glomerulonephritis (HP:0000099) | 2.64107265 |
| 27 | Alkalosis (HP:0001948) | 2.58763036 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58400543 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58400543 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58400543 |
| 31 | Nasal polyposis (HP:0100582) | 2.53219097 |
| 32 | Tubulointerstitial fibrosis (HP:0005576) | 2.52486545 |
| 33 | Hypokalemic alkalosis (HP:0001949) | 2.52408983 |
| 34 | Cystic liver disease (HP:0006706) | 2.51504759 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49561984 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.49561984 |
| 37 | Nephronophthisis (HP:0000090) | 2.49072016 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.44869799 |
| 39 | Abnormality of renal excretion (HP:0011036) | 2.39462140 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 2.36374967 |
| 41 | Pancreatic fibrosis (HP:0100732) | 2.36208822 |
| 42 | Hyperventilation (HP:0002883) | 2.34124367 |
| 43 | Nephritis (HP:0000123) | 2.33568330 |
| 44 | Polydipsia (HP:0001959) | 2.32538744 |
| 45 | Abnormal drinking behavior (HP:0030082) | 2.32538744 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25397570 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.24017103 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.24017103 |
| 49 | Polyuria (HP:0000103) | 2.22705797 |
| 50 | Abnormality of complement system (HP:0005339) | 2.22329931 |
| 51 | Congenital sensorineural hearing impairment (HP:0008527) | 2.20925120 |
| 52 | Tubulointerstitial nephritis (HP:0001970) | 2.16755637 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.16130737 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.16130737 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16035699 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15820981 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15820981 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15820981 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.14949632 |
| 60 | Tubulointerstitial abnormality (HP:0001969) | 2.11308933 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.09844751 |
| 62 | Amelogenesis imperfecta (HP:0000705) | 2.09706735 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.09543942 |
| 64 | Hypokalemia (HP:0002900) | 2.09063891 |
| 65 | Facial shape deformation (HP:0011334) | 2.08487391 |
| 66 | Potter facies (HP:0002009) | 2.08487391 |
| 67 | Abnormal urine output (HP:0012590) | 2.08266466 |
| 68 | Chronic hepatic failure (HP:0100626) | 2.08090822 |
| 69 | Chronic sinusitis (HP:0011109) | 2.02358579 |
| 70 | Malnutrition (HP:0004395) | 1.97556777 |
| 71 | Stage 5 chronic kidney disease (HP:0003774) | 1.97515155 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94328421 |
| 73 | Glycosuria (HP:0003076) | 1.93293167 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 1.93293167 |
| 75 | Vascular calcification (HP:0004934) | 1.93045643 |
| 76 | Fat malabsorption (HP:0002630) | 1.92784743 |
| 77 | Infertility (HP:0000789) | 1.89304768 |
| 78 | Congenital hepatic fibrosis (HP:0002612) | 1.86944151 |
| 79 | Recurrent sinusitis (HP:0011108) | 1.86855669 |
| 80 | Myositis (HP:0100614) | 1.86680272 |
| 81 | Intrahepatic cholestasis (HP:0001406) | 1.85392308 |
| 82 | Abnormality of potassium homeostasis (HP:0011042) | 1.82536424 |
| 83 | Occipital encephalocele (HP:0002085) | 1.81433884 |
| 84 | Bronchitis (HP:0012387) | 1.80590459 |
| 85 | Increased circulating renin level (HP:0000848) | 1.78204077 |
| 86 | Xanthomatosis (HP:0000991) | 1.76416515 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76229658 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69924401 |
| 89 | Pigmentary retinal degeneration (HP:0001146) | 1.69484974 |
| 90 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69365668 |
| 91 | Furrowed tongue (HP:0000221) | 1.67875377 |
| 92 | Male pseudohermaphroditism (HP:0000037) | 1.67624912 |
| 93 | Cardiovascular calcification (HP:0011915) | 1.66814091 |
| 94 | Thyroid-stimulating hormone excess (HP:0002925) | 1.66776277 |
| 95 | Loss of speech (HP:0002371) | 1.64751890 |
| 96 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.63472698 |
| 97 | Orchitis (HP:0100796) | 1.63156819 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 1.62459021 |
| 99 | Optic neuritis (HP:0100653) | 1.60567011 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 1.60567011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.82515097 |
| 2 | MAPK15 | 3.78895570 |
| 3 | EPHA2 | 2.90747600 |
| 4 | TAOK3 | 2.55858326 |
| 5 | MAPKAPK3 | 2.29610202 |
| 6 | OXSR1 | 2.06549970 |
| 7 | ADRBK2 | 1.92423578 |
| 8 | STK39 | 1.81185977 |
| 9 | WNK3 | 1.77313199 |
| 10 | EPHA3 | 1.76683537 |
| 11 | FER | 1.70993000 |
| 12 | GRK1 | 1.68592294 |
| 13 | PIK3CA | 1.67492927 |
| 14 | MAP2K6 | 1.62843455 |
| 15 | SIK1 | 1.48097074 |
| 16 | ERN1 | 1.45943212 |
| 17 | ACVR1B | 1.44878121 |
| 18 | MST1R | 1.43605495 |
| 19 | PINK1 | 1.39776462 |
| 20 | TNK2 | 1.38586838 |
| 21 | KIT | 1.26395024 |
| 22 | TRIB3 | 1.21522214 |
| 23 | NLK | 1.18533147 |
| 24 | MAP2K2 | 1.13402087 |
| 25 | EPHB2 | 1.12868352 |
| 26 | PKN2 | 1.12754085 |
| 27 | CHUK | 1.09283976 |
| 28 | RPS6KA2 | 1.08570003 |
| 29 | WNK4 | 1.07629182 |
| 30 | EPHB1 | 1.06514418 |
| 31 | TRPM7 | 1.05819906 |
| 32 | TBK1 | 1.03521023 |
| 33 | SGK2 | 1.03255570 |
| 34 | INSRR | 1.02478581 |
| 35 | MATK | 0.99191576 |
| 36 | IKBKE | 0.98883160 |
| 37 | MUSK | 0.98623034 |
| 38 | ADRBK1 | 0.96013744 |
| 39 | GRK7 | 0.94043600 |
| 40 | RIPK1 | 0.92225437 |
| 41 | MYLK | 0.91473547 |
| 42 | AKT3 | 0.90702784 |
| 43 | TYK2 | 0.89154267 |
| 44 | MAP3K2 | 0.88756101 |
| 45 | TGFBR2 | 0.87484735 |
| 46 | DAPK2 | 0.86654693 |
| 47 | PRKAA2 | 0.86310637 |
| 48 | LMTK2 | 0.85416532 |
| 49 | IKBKB | 0.85397005 |
| 50 | MAP4K2 | 0.84183123 |
| 51 | ZAP70 | 0.84116071 |
| 52 | MAP3K3 | 0.81674320 |
| 53 | CAMK1D | 0.80662452 |
| 54 | MAP3K6 | 0.80273038 |
| 55 | GRK6 | 0.79897253 |
| 56 | CDC42BPA | 0.77453983 |
| 57 | ERBB2 | 0.77208046 |
| 58 | TIE1 | 0.75980567 |
| 59 | MAPK13 | 0.75263859 |
| 60 | SGK223 | 0.73609961 |
| 61 | SGK494 | 0.73609961 |
| 62 | IRAK1 | 0.72373452 |
| 63 | CSF1R | 0.72092865 |
| 64 | TXK | 0.71862508 |
| 65 | PRKD2 | 0.68466970 |
| 66 | RPS6KA6 | 0.68205735 |
| 67 | BLK | 0.65136346 |
| 68 | FGFR3 | 0.64979214 |
| 69 | MAP2K4 | 0.64458368 |
| 70 | JAK1 | 0.62720330 |
| 71 | PDPK1 | 0.61053160 |
| 72 | SGK3 | 0.60917909 |
| 73 | HIPK2 | 0.60614777 |
| 74 | PRKCE | 0.59797508 |
| 75 | MARK2 | 0.59711455 |
| 76 | PRKCZ | 0.59144686 |
| 77 | MAP3K7 | 0.58748247 |
| 78 | CAMKK2 | 0.58106168 |
| 79 | CSK | 0.56885067 |
| 80 | LATS1 | 0.55826959 |
| 81 | TLK1 | 0.54440240 |
| 82 | PTK6 | 0.53532772 |
| 83 | PRKCQ | 0.52507298 |
| 84 | TAOK1 | 0.51681961 |
| 85 | CASK | 0.49552927 |
| 86 | BMPR1B | 0.49121139 |
| 87 | GSK3A | 0.48110170 |
| 88 | MAP4K1 | 0.47952591 |
| 89 | RPS6KL1 | 0.47616060 |
| 90 | RPS6KC1 | 0.47616060 |
| 91 | PAK3 | 0.47165889 |
| 92 | MET | 0.47106105 |
| 93 | PIK3CG | 0.47001356 |
| 94 | DYRK1B | 0.46929866 |
| 95 | RET | 0.46928976 |
| 96 | BTK | 0.46846059 |
| 97 | PDK1 | 0.46113311 |
| 98 | TEC | 0.44342505 |
| 99 | CAMK1G | 0.44268268 |
| 100 | MAPK7 | 0.43975082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.74166181 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.58175753 |
| 3 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.57583747 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.51287040 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.48143208 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44401711 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.38734574 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.33008318 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.28872232 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.22068398 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.93740067 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86096557 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78316901 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76745652 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76724330 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59969087 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59756928 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.56497688 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56266342 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52325069 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.49085492 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47969434 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45718499 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44872400 |
| 25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42991244 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42863548 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41284988 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.38629399 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37917430 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37339223 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.30378760 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28909909 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24788741 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23704204 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.20520725 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20146116 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.18356443 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17949805 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17132594 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.16418418 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.05031130 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.03016250 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99240798 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98824027 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97778836 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97500844 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92392173 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91066123 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90553057 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89079067 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81434365 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80040259 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.79264169 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77313636 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75136973 |
| 56 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74373951 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70768077 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69902846 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69757745 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69524520 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68903731 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68677890 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64275819 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.60246589 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55781900 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.55610559 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54453526 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51633934 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51059157 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.50580533 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49178814 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.48920294 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47867247 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.45799114 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44427320 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43691370 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41966020 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41253575 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40701968 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40506750 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39646556 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36562452 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.36249267 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35858182 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.34582941 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34171000 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33393433 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31978093 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30048157 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.29579988 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27359747 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26903751 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25265239 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24334259 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24013631 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23914952 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23593288 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.23556110 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.23111448 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.23101080 |

